TRENDING TOPICS
3286 articles found for "investing"
Walmart hit a 52-week high, Boeing surged 3%, and GE Vernova gained 1% as industrial and consumer staples stocks led the Dow Jones to fresh records while mega-cap tech lagged.
President Trump signed an executive order directing the Pentagon to buy coal-fired electricity and allocated $625 million to keep coal plants open. Peabody Energy surged 17% on the news.
Roku reports Q4 2025 results tonight with $1.35 billion in expected revenue and a projected swing to profitability at 28 cents per share. Platform advertising growth near 15% and an Amazon partnership could reshape the company's trajectory.
Brent crude hovers near $70 as geopolitical risk from US-Iran tensions collides with the largest US crude inventory build since November 2023. The oil market faces a tug-of-war between fear and fundamentals.
Vertex Pharmaceuticals reports Q4 2025 results after the close on February 12, with analysts expecting $3.16 billion in revenue and $5.15 EPS as the biotech giant's Casgevy gene therapy and Journavx pain drug begin diversifying revenue beyond its dominant cystic fibrosis franchise.
Arista Networks releases Q4 2025 results after the close on February 12, with analysts expecting $2.38 billion in revenue and $0.75 EPS as AI data center buildouts drive unprecedented demand for high-speed networking equipment.
AppLovin reported Q4 2025 earnings with $1.66 billion in revenue beating estimates, $3.24 EPS crushing the $2.96 consensus, and an 84% adjusted EBITDA margin, yet shares fell 3% after hours as ad-tech valuations face mounting pressure.
Palo Alto Networks completed its acquisition of CyberArk on February 11, creating a unified cybersecurity platform that protects human, machine, and AI agent identities across the enterprise.
Coinbase releases fourth quarter and full year 2025 results on February 12, with revenue expected to decline 19% year over year as Bitcoin's retreat below $67,000 and a 34% stock decline test the exchange's transformation strategy.
Applied Materials reports fiscal Q1 2026 earnings after the close on February 12, with analysts expecting $2.20 EPS and $6.85 billion in revenue as AI chip manufacturing demand reshapes the semiconductor equipment landscape.
The FDA issued a Refusal-to-File letter for Moderna's seasonal flu vaccine mRNA-1010, citing clinical trial deficiencies. The stock dropped as much as 14% intraday as analysts question the company's path beyond COVID.
Enflame, Moore Threads, MetaX, and Biren Technology are racing to list on Chinese exchanges, with Moore Threads surging 425% and MetaX 693% on their debut days as Beijing accelerates semiconductor self-reliance.